home / stock / dnay / dnay quote
Last: | $1.30 |
---|---|
Change Percent: | 0.0% |
Open: | $1.2 |
Close: | $1.30 |
High: | $1.3093 |
Low: | $1.2 |
Volume: | 19,956 |
Last Trade Date Time: | 01/03/2023 03:40:04 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.3 | $1.2 | $1.3 | $1.3093 | $1.2 | 19,956 | 01-03-2023 |
$1.2 | $1.23 | $1.2 | $1.31 | $1.17 | 83,358 | 01-02-2023 |
$1.2 | $1.23 | $1.2 | $1.31 | $1.17 | 83,358 | 12-30-2022 |
$1.2318 | $1.25 | $1.2318 | $1.27 | $1.174 | 38,553 | 12-29-2022 |
$1.21 | $1.18 | $1.21 | $1.23 | $1.1401 | 24,399 | 12-28-2022 |
$1.19 | $1.31 | $1.19 | $1.31 | $1.14 | 42,416 | 12-27-2022 |
$1.24 | $1.123 | $1.24 | $1.26 | $1.123 | 49,195 | 12-26-2022 |
$1.24 | $1.123 | $1.24 | $1.26 | $1.123 | 49,195 | 12-23-2022 |
$1.16 | $1.17 | $1.16 | $1.17 | $1.1 | 12,976 | 12-22-2022 |
$1.17 | $1.1165 | $1.17 | $1.1822 | $1.11 | 25,418 | 12-21-2022 |
$1.12 | $1.19 | $1.12 | $1.215 | $1.1 | 38,157 | 12-20-2022 |
$1.15 | $1.29 | $1.15 | $1.29 | $1.13 | 28,593 | 12-19-2022 |
$1.21 | $1.31 | $1.21 | $1.31 | $1.2 | 206,916 | 12-16-2022 |
$1.2 | $1.18 | $1.2 | $1.24 | $1.18 | 18,943 | 12-15-2022 |
$1.21 | $1.25 | $1.21 | $1.28 | $1.1901 | 49,096 | 12-14-2022 |
$1.26 | $1.22 | $1.26 | $1.3 | $1.22 | 35,841 | 12-13-2022 |
$1.23 | $1.2 | $1.23 | $1.26 | $1.14 | 69,922 | 12-12-2022 |
$1.18 | $1.25 | $1.18 | $1.25 | $1.15 | 72,644 | 12-09-2022 |
$1.2 | $1.17 | $1.2 | $1.22 | $1.1001 | 43,463 | 12-08-2022 |
$1.13 | $1.24 | $1.13 | $1.24 | $1.0801 | 221,406 | 12-07-2022 |
News, Short Squeeze, Breakout and More Instantly...
Codex DNA Inc. Company Name:
DNAY Stock Symbol:
NASDAQ Market:
-- Record revenue of $6.7M in 3QFY22; Increase of 140% over $2.8M 3QFY 2021 -- BioXp® Kit Revenue increased to $884k, or 69% in 3QFY22 over 3QFY2021 -- Increases revenue guidance to $23 million to $25 million for the full year fiscal 2022 SAN DIEGO, Nov. 08, 2022 (GLOBE N...
SAN DIEGO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its third quarter 2022 financial results on Tuesday, November 8, 2022, after the market closes. In conjunction ...
SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, and Cellibre, a leading manufacturing technology company, today announced initiation of work under a collaboration to optimize the development and valid...